Project Omega raises $80M Series A for nuclear recycling facility and power systems

Project Omega has raised $80M in Series A funding led by B Capital to begin construction of a nuclear fuel recycling facility and advance its X Series power products.
- Raised
- $80M
- Round
- Series A
- Investors
- 10
- Investors
- B Capitalnoa VC645 VenturesStarship VenturesMantis VenturesDecisive PointVirta VenturesPace VenturesEssential CapitalWashington Harbour Partners
- Target market
- Defense, space and remote operations; commercial, medical and scientific isotope users
- Use of funds
- Supporting a pilot facility for domestic isotope recovery and feedstock production, beginning construction of a nuclear fuel recycling facility, and advancing long-duration power systems and X Series technology and manufacturing
Get started
Create a free account to read the full story.
Quick Answers
What is the latest news about Project Omega?
Project Omega has raised $80M in Series A funding led by B Capital to begin construction of a nuclear fuel recycling facility and advance its X Series power products.
What does Project Omega do?
Project Omega recycles used nuclear fuel through a non-aqueous pyroprocessing platform to produce long-duration power sources, reactor feedstock and isotopes for commercial, medical and scientific uses.
How much did Project Omega raise?
Project Omega raised $80M in its Series A.
Who invested in Project Omega?
Investors named in this Series A include B Capital, noa VC, 645 Ventures, Starship Ventures, Mantis Ventures, Decisive Point, Virta Ventures and Pace Ventures and 2 others.
How will Project Omega use the funding?
Project Omega plans to use the money for supporting a pilot facility for domestic isotope recovery and feedstock production, beginning construction of a nuclear fuel recycling facility, and advancing long-duration power systems and X Series technology and manufacturing.
Where is Project Omega based?
Project Omega is based in USA.
Who are the key people at Project Omega?
Key people named in this report: Dr. Stafford Sheehan (founder and CEO).
